Actinium Pharmaceuticals, Inc.
ATNM · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $73 | $77 | $109 | $78 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $2 | $2 | $2 |
| Total Curr. Assets | $75 | $78 | $111 | $80 |
| Property Plant & Equip (Net) | $2 | $3 | $3 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $3 | $3 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $77 | $81 | $114 | $80 |
| Liabilities | – | – | – | – |
| Payables | $8 | $8 | $10 | $6 |
| Short-Term Debt | $1 | $1 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $0 | $1 |
| Total Curr. Liab. | $8 | $8 | $11 | $7 |
| LT Debt | $1 | $2 | $2 | $0 |
| Deferred Rev, NC | $35 | $35 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $35 | $0 |
| Total NC Liab. | $36 | $37 | $37 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $3 | $0 |
| Total Liabilities | $44 | $45 | $48 | $7 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$376 | -$338 | -$289 | -$256 |
| AOCI | $0 | $0 | -$0 | -$0 |
| Other Equity | $409 | $374 | $355 | $329 |
| Total Equity | $33 | $36 | $66 | $74 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $77 | $81 | $114 | $80 |
| Net Debt | -$71 | -$75 | -$106 | -$78 |